Alkermes plc Reports Financial Results for the Periods Ended Dec. 31, 2013 and Provides Financial Expectations for 2014

[at noodls] – – Achieved Record Revenues of $596 Million and Non-GAAP Diluted EPS of $1.19forCalendar 2013 – – Expects Pivotal Data for Aripiprazole Lauroxil in First Half of 2014 – DUBLIN–(BUSINESS WIRE)–Feb. 27, … more

View todays social media effects on ALKS

View the latest stocks trending across Twitter. Click to view dashboard

See who Alkermes is hiring next, click here to view